Merck & Co., Inc.
13 holdingsFiling period: 2026-06-30Current AUM: $818.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PSNL | Personalis Inc | 14.04M | $188.2M | $223.0M | 27.24% | -- | 2026-06-30 |
| 2 | MRNA | Moderna Inc | 2.31M | $161.6M | $459.0M | 56.05% | -- | 2026-06-30 |
| 3 | KYMR | Kymera Therapeutics Inc | 772.2K | $88.5M | $88.7M | 10.83% | -- | 2026-06-30 |
| 4 | AKTS | Aktis Oncology Inc | 952.8K | $30.7M | $15.0M | 1.83% | -- | 2026-06-30 |
| 5 | EIKN | Eikon Therapeutics Inc | 1.67M | $21.7M | $9.2M | 1.13% | -- | 2026-06-30 |
| 6 | TRDA | Entrada Therapeutics Inc | 1.74M | $12.8M | $8.3M | 1.01% | -- | 2026-06-30 |
| 7 | STRO | Sutro Biopharma Inc | 272.4K | $9.0M | $2.4M | 0.30% | -- | 2026-06-30 |
| 8 | ALEC | Alector Inc | 3.55M | $7.1M | $6.5M | 0.79% | -- | 2026-06-30 |
| 9 | EVAX | Evaxion Biotech A/S | 1.21M | $3.8M | $3.7M | 0.46% | -- | 2026-06-30 |
| 10 | VRDN | Viridian Therapeutics Inc | 93.4K | $1.7M | $2.2M | 0.27% | -- | 2026-06-30 |
| 11 | XLO | Xilio Therapeutics Inc | 106.0K | $1.0M | $774K | 0.09% | -- | 2026-06-30 |
| 12 | HURA | Tuhura Biosciences Inc | 19.4K | $45K | $39K | 0.00% | -- | 2026-06-30 |
| 13 | NEUP | Neuphoria Therapeutics Inc | 10.0K | $43K | $33K | 0.00% | -- | 2026-06-30 |
← Scroll →